Galectin-3 as a potential biomarker of metabolic disorders and cardiovascular remodeling in patients with hypertension and type 2 diabetes
Vessel Plus · 2017
DOI: 10.20517/2574-1209.2016.10 ↗Kurz gefasst
Fachartikel in der Zeitschrift Vessel Plus, 2017. Verfasst von Lesya Bobronnikova. Die Arbeit wurde bisher 13-mal zitiert (Crossref).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Vessel Plus is an open acccess journal, which publishes articles related to vascular diseases, including acute respiratory distress syndrome, aneurysm, atherosclerosis, hypertension, stroke, peripheral vascular or pulmonary vascular diseases, etc.
Zitieren
APA
Bobronnikova, L. (2017). Galectin-3 as a potential biomarker of metabolic disorders and cardiovascular remodeling in patients with hypertension and type 2 diabetes. Vessel Plus. https://doi.org/10.20517/2574-1209.2016.10
Vancouver
Bobronnikova L. Galectin-3 as a potential biomarker of metabolic disorders and cardiovascular remodeling in patients with hypertension and type 2 diabetes. Vessel Plus. 2017. doi:10.20517/2574-1209.2016.10
BibTeX
@article{Bobronnikova2017,
author = {Bobronnikova, Lesya},
title = {Galectin-3 as a potential biomarker of metabolic disorders and cardiovascular remodeling in patients with hypertension and type 2 diabetes},
journal = {Vessel Plus},
year = {2017},
doi = {10.20517/2574-1209.2016.10}
}
EUVIMED